Difference between revisions of "LII:COVID-19 Testing, Reporting, and Information Management in the Laboratory"

From LIMSWiki
Jump to navigationJump to search
(Updated for Edition 2.0)
(November updates)
Line 2: Line 2:
'''Title''': ''COVID-19 Testing, Reporting, and Information Management in the Laboratory''
'''Title''': ''COVID-19 Testing, Reporting, and Information Management in the Laboratory''


'''Edition''': Edition 2.0
'''Edition''': Fall 2020


'''Author for citation''': Shawn E. Douglas
'''Author for citation''': Shawn E. Douglas
Line 8: Line 8:
'''License for content''': [https://creativecommons.org/licenses/by-sa/4.0/ Creative Commons Attribution-ShareAlike 4.0 International]
'''License for content''': [https://creativecommons.org/licenses/by-sa/4.0/ Creative Commons Attribution-ShareAlike 4.0 International]


'''Publication date''': August 2020
'''Publication date''': November 2020




This guide discusses the evolving status of [[laboratory]] testing, reporting, and [[information management]] for the [[COVID-19]] disease and pandemic. The focus is primarily on testing and reporting in the United States, but other parts of the world are also addressed. It also examines the disease's history, what makes it difficult to combat, and what diagnostic testing methods are currently available. Additionally, the guide examines what testing workflow for COVID-19 is like, along with the equipment, software, and reporting required by testing labs, as well as additional benefits and challenges of [[laboratory informatics]] in disease testing and public health. This guide closes with final remarks, as well as a listing of associated resources, including guidance documents, web portals, and key reading.  
This guide discusses the evolving status of [[laboratory]] testing, reporting, and [[information management]] for the [[COVID-19]] disease and pandemic. The focus is primarily on testing and reporting in the United States, but other parts of the world are also addressed. It also examines the disease's history, what makes it difficult to combat, and what diagnostic testing methods are currently available. Additionally, the guide examines what testing workflow for COVID-19 is like, along with the equipment, software, and reporting required by testing labs, as well as additional benefits and challenges of [[laboratory informatics]] in disease testing and public health. This guide closes with final remarks, as well as a listing of associated resources, including guidance documents, web portals, and key reading.  


This guide is published in a time when information about COVID-19 and the SARS-CoV-2 virus is still changing rapidly. An attempt to make small, incremental updates to the guide will be made as the state of reasearch and testing continues to shift. The occasional major update will increment the edition a full number. August's 2.0 edition brings with it a new Chapter 3 (bumping the prior Chapter 3 and 4 back) focusing on how a laboratory can get set up with COVID-19 and other respiratory virus testing.
This guide is published in a time when information about COVID-19 and the SARS-CoV-2 virus is still changing rapidly. An attempt to make small, incremental updates to the guide will be made as the state of reasearch and testing continues to shift. The occasional major update will increment the edition a full number. November's Fall 2020 edition brings with it a number of small additions and updates, including updates on statistics, long-term health issues, testing guidance, available test kits, coding and reporting issues, interoperability, and contact tracing, among other topics.


The table of contents for ''COVID-19 Testing, Reporting, and Information Management in the Laboratory'' is as follows:  
The table of contents for ''COVID-19 Testing, Reporting, and Information Management in the Laboratory'' is as follows:  
Line 38: Line 38:
:2.4 Current test methods and their differences
:2.4 Current test methods and their differences
::2.4.1 Background on the laboratory testing environment
::2.4.1 Background on the laboratory testing environment
::2.4.2 PCR-based
::2.4.2 PCR-based methods
::2.4.3 LFA and isothermal amplification methods
::2.4.3 LFA and isothermal amplification methods
::2.4.4 Blood serum
::2.4.4 Blood serum
Line 63: Line 63:
::3.3.2 Reporting
::3.3.2 Reporting
::3.3.3 Billing, Medicare, and Medicaid
::3.3.3 Billing, Medicare, and Medicaid
::3.3.4 Biosafety


4. [[LII:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Workflow and information management for COVID-19 (and other respiratory diseases)|Workflow and information management for COVID-19 (and other respiratory diseases)]]
4. [[LII:COVID-19 Testing, Reporting, and Information Management in the Laboratory/Workflow and information management for COVID-19 (and other respiratory diseases)|Workflow and information management for COVID-19 (and other respiratory diseases)]]

Revision as of 21:47, 21 November 2020

SARS-CoV-2 without background.png

Title: COVID-19 Testing, Reporting, and Information Management in the Laboratory

Edition: Fall 2020

Author for citation: Shawn E. Douglas

License for content: Creative Commons Attribution-ShareAlike 4.0 International

Publication date: November 2020


This guide discusses the evolving status of laboratory testing, reporting, and information management for the COVID-19 disease and pandemic. The focus is primarily on testing and reporting in the United States, but other parts of the world are also addressed. It also examines the disease's history, what makes it difficult to combat, and what diagnostic testing methods are currently available. Additionally, the guide examines what testing workflow for COVID-19 is like, along with the equipment, software, and reporting required by testing labs, as well as additional benefits and challenges of laboratory informatics in disease testing and public health. This guide closes with final remarks, as well as a listing of associated resources, including guidance documents, web portals, and key reading.

This guide is published in a time when information about COVID-19 and the SARS-CoV-2 virus is still changing rapidly. An attempt to make small, incremental updates to the guide will be made as the state of reasearch and testing continues to shift. The occasional major update will increment the edition a full number. November's Fall 2020 edition brings with it a number of small additions and updates, including updates on statistics, long-term health issues, testing guidance, available test kits, coding and reporting issues, interoperability, and contact tracing, among other topics.

The table of contents for COVID-19 Testing, Reporting, and Information Management in the Laboratory is as follows:


1. Overview of COVID-19 and its challenges

1.1 COVID-19: The terminology
1.2 COVID-19: History and impact (so far)
1.3 Challenges of managing the disease in the human population

2. Diagnostic testing of COVID-19 and other coronaviruses

2.1 Testing terminology
2.1.1 Introduction
2.1.2 Polymerase chain reaction (PCR)
2.1.3 Lateral flow assay (LFA)
2.2 Testing conducted on previous coronaviruses
2.2.1 Severe acute respiratory syndrome (SARS)
2.2.2 Middle East respiratory syndrome (MERS)
2.2.3 The common cold
2.3 Organizational and agency guidance on COVID-19 testing
2.3.1 Regulatory considerations: HIPAA and CLIA
2.4 Current test methods and their differences
2.4.1 Background on the laboratory testing environment
2.4.2 PCR-based methods
2.4.3 LFA and isothermal amplification methods
2.4.4 Blood serum
2.4.5 Antigen tests
2.4.6 Testing alternatives and challenges

3. Adding COVID-19 and other virus testing to your laboratory

3.1 What methodologies will you use?
3.1.1 PCR
3.1.2 Pooled testing
3.1.3 Rapid antigen testing
3.1.4 LAMP and CRISPR
3.1.5 Point-of-care and other alternative testing
3.2 What kind of space, equipment, and supplies will you need?
3.2.1 Laboratory space arrangements
3.2.2 Instruments and assays
3.2.3 Reagents
3.2.4 Consumables
3.2.5 Software and services
3.2.6 Major vendors and consultants
3.3 What other considerations should be made?
3.3.1 U.S. regulatory compliance
3.3.2 Reporting
3.3.3 Billing, Medicare, and Medicaid
3.3.4 Biosafety

4. Workflow and information management for COVID-19 (and other respiratory diseases)

4.1 Laboratory informatics and workflow management
4.1.1 Does the system provide a flexible provider portal?
4.1.2 Does the system allow for the flexible addition of users, providers, and patients?
4.1.3 Does the system allow for laboratory workflows sympathetic to COVID-19 and other types of respiratory illness testing?
4.1.4 Does the system allow for interfacing with most instruments currently used for testing for COVID-19?
4.1.5 Does the system allow for versatile viewing and reporting of COVID-19 results?
4.2 Laboratory informatics and reporting requirements
4.2.1 ICD, CPT, and HCPCS coding
4.2.2 Reporting to local and regional health departments
4.3 Additional benefits and challenges of informatics in disease testing and public health
4.3.1 System interoperability
4.3.2 Contact tracing

5. Final thoughts and additional resources

5.1 Final thoughts
5.2 Key guidance documents
5.3 Web portals
5.4 Key journal articles
5.5 Public health lab directory
5.6 Test kit and other resources
5.7 Public health laboratory informatics vendors